Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a Phase 2b, multicenter, multinational, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of 4 doses of cenerimod versus placebo in adult subjects with moderately to severely active, autoantibody‐positive systemic lupus erythematosus (SLE).
Epistemonikos ID: f8f8aa18adc5b3c2f557b4701d6352d3c4821a9f
First added on: Apr 30, 2024